David, one other thing
Phase 2 trials confirmed no changes to fasting glucose, insulin, or IGF-1 levels after 12 weeks of AOD-9604 dosing, making it mechanistically distinct from full growth hormone therapy
Peptide therapies like the ones we discussed take a complementary approach : rather than suppress appetite dramatically, they optimize the bodys metabolism and hormones to encourage fat loss and muscle retention
In states of obesity and metabolic dysfunction, NNMT is often overexpressed in adipose tissue, depleting nicotinamide and reducing NAD+ availability
And given how quickly its sold out, combined with its very recent 2021 release into the market, its unlikely you will be able to get your hands on it soon
Once any part of a course has been accessed or downloaded, refunds are not available